Biopharma Cred. Regulatory News (BPCR)

9 september 2020

BioPharma Credit plc

(the "Company")

LEXICON Pharmaceuticals PREPAYMENT

Pharmakon Advisors, the Investment Manager of BioPharma Credit PLC (the "Company"), notes that Lexicon Pharmaceuticals ("Lexicon") has repaid in full its $150 million secured term loan, of which the Company owned $124.5 million. As a result of the repayment, the Company received $132.3 million today from Lexicon, comprised of $124.5 million in principal, $2.2 million in accrued interest and $5.6 million in make-whole amount and prepayment fees. This investment generated an IRR of 12.1%.

Enquiries

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 500

Buchanan

+44 (0)20 7466 5000 / biopharmacredit@buchanan.uk.com

David Rydell

Mark Court

Jamie Hooper

Henry Wilson

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24